Intrinsic Value of S&P & Nasdaq Contact Us

Fresh Tracks Therapeutics, Inc. FRTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — FRTX

Fresh Tracks Therapeutics, Inc. (FRTX) has a market capitalization of $5.59M and trades at $0.94. The 52-week range is 0.03-1.0325.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1, Earnings Per Share (EPS) of $-0.96, annual revenue of $8.01M.

The stock has a beta of 1.17, operates in the Healthcare sector.

Trading Data
Current Price$0.94
52-Week Range0.03-1.0325
Volume2.16K
Avg Volume (30D)2.67K
Market Cap$5.59M
Beta (1Y)1.17
Company
IPO Date1993-03-10
Employees4
CEOAlbert Nicholas Marchio II
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS10802T2042
CUSIP10802T204
Income (Latest Year)
Revenue$8.01M
Gross Profit$8.01M
EBITDA$-5.65M
Operating Income$-6.36M
Net Income$-5.69M
EPS$-0.96
EPS Diluted$-0.96
Shares Outstanding$5.91M
Balance Sheet (Latest Year)
Total Assets$11.59M
Current Assets$11.55M
Cash & ST Investments$10.87M
Total Liabilities$1.66M
Net Debt$-10.87M
Total Equity$9.93M
Valuation Ratios
P/E Ratio-1
P/S Ratio0.7
P/B Ratio0.56
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message